2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow fevipiprant: new trials by email Literature Review of fevipiprant trials Research Report on fevipiprant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Proof-of-mechanism Study of Multiple, Oral Doses of Fevipiprant (QAW039) in COPD Patients With Eosinophilia QAW039, Placebo - Chronic Obstructive Pulmonary Disease | Phase 2 | Terminated | Novartis Pharmaceuticals | 9 | 2019-05-21 | 2021-10-08 |
| Pharmacokinetics, Safety and Tolerability of Fevipiprant Delivered Via a Once Daily Chewable Tablet in Children Aged 6 to < 12 Years With Asthma Fevipiprant - Asthma | Phase 2 | Terminated | Novartis Pharmaceuticals | 11 | 2019-05-01 | 2026-01-13 |
Asthma (1) · Eosinophilia (1) · Pulmonary Disease, Chronic Obstructive (1)
Germany (1) · United Kingdom (1) · United States (1)
2018 (1)